Ibiome Biology Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $13.8M

  • Investors
  • 6

Ibiome Biology General Information

Description

Developer of gut microbiome pharmaceuticals, designed for immune therapies and clinical treatment solutions. The company specializes in developing gut microbiome-based drugs with research in immune therapies, providing healthcare and pharmaceutical industries with innovative solutions for metabolic diseases, cancer, inflammatory bowel disease and autoimmune disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 16th Floor, Building E, Intelligent Equipment Technology Park
  • No. 3963, Susong Road, Hefei Economic and Technological Development Zone
  • Hefei, Anhui 240000
  • China
+86 0551
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 16th Floor, Building E, Intelligent Equipment Technology Park
  • No. 3963, Susong Road, Hefei Economic and Technological Development Zone
  • Hefei, Anhui 240000
  • China
+86 0551

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ibiome Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 20-Nov-2023 $13.8M Completed Generating Revenue
1. Early Stage VC 02-Dec-2021 Completed Generating Revenue
To view Ibiome Biology’s complete valuation and funding history, request access »

Ibiome Biology Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anhui Chuanggu Equity Investment Fund Management Growth/Expansion Minority
Anhui Zhongan Capital Growth/Expansion Minority
CICC Capital PE/Buyout Minority
Hefei Innovation Technology Venture Capital Growth/Expansion Minority
Walden International Shanghai Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ibiome Biology FAQs

  • When was Ibiome Biology founded?

    Ibiome Biology was founded in 2021.

  • Where is Ibiome Biology headquartered?

    Ibiome Biology is headquartered in Hefei, China.

  • What industry is Ibiome Biology in?

    Ibiome Biology’s primary industry is Drug Discovery.

  • Is Ibiome Biology a private or public company?

    Ibiome Biology is a Private company.

  • What is Ibiome Biology’s current revenue?

    The current revenue for Ibiome Biology is .

  • How much funding has Ibiome Biology raised over time?

    Ibiome Biology has raised $13.8M.

  • Who are Ibiome Biology’s investors?

    Anhui Chuanggu Equity Investment Fund Management, Anhui Zhongan Capital, CICC Capital, Hefei Innovation Technology Venture Capital, and Walden International Shanghai are 5 of 6 investors who have invested in Ibiome Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process